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Identity 
Other names: FLJ94509; GFI-1; SCN2; ZNF163 








The GFI1 locus consists of 7 exons of which 6 are 
coding. Depending on different reported variants, the
position of the first, non-coding, exon 1, can vary. 
Pseudogene 
None known. 
Figure 1. GFI1 protein (from Möröy and Khandanpour). 
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Protein 
Description 
Both human and murine Gfi1 proteins consist of 422 
amino acids and have a mass of 45297 Da. The 
isoelectric point is 9.24. Gfi1 contains six c-terminal 
C2H2-type zinc-finger domains and an N-terminal 
SNAG domain critical for its repressor activity (figure 
1). Zinc fingers 3 to 5 of Gfi1 recognize and bind to the 
DNA sequence taAATCac(t/a)gca. Zinc fingers 1, 2 
and 6 are required for the interaction with other 
proteins (Bell et al., 1995; Duan and Horwitz, 2003; 
Gilks et al., 1993; Grimes et al., 1996; Hock et al.,
2003; Person et al., 2003; Zweidler-Mckay et al., 1996) 
Expression 
Mice carrying a GFP reporter gene within the Gfi1 
locus allowed studying in detail Gfi1 expression during 
differentiation of the different compartments in vivo 
(Yücel et al., 2004; Zeng et al., 2004). Gfi1 plays a 
major role in the stem cell fraction, B-, T- and myeloid 
compartment, whereas it is relatively low expressed in 
the megakaryocytic-erythroid compartment. In this cell
population, the Gfi1 paralogue Gfi1b exerts important 
functions. To facilitate the overview we will describe 
the expression for each compartment separately. 
Hematopoietic stem cells and early progenitors 
All blood cells originate from hematopoietic stem cells 
(HSCs). These cells have a high self-renewal capacity 
and upon cell division, either one HSC gives rise to two 
HSC daughter cells or to one HSC and one so-called 
Multipotential Progenitors (MPPs). These MPPs 
differentiate via MPP1, MPP2 and MPP3 to the 
different progenitors of the myeloid, erythroid, 
megakaryocytic and lymphoid compartments. Gfi1 is 
present in HSCs, albeit at low levels compared to HSC 
progeny such as MPP1 and MPP2 (measured in Gfi1: 
GFP knockin reporter mice (Khandanpour et al., 
2010b). 
Myeloid compartment  
MPPs can differentiate to so called common myeloid 
progenitor cells (CMPs), which in turn give rise to 
either megakaryocyte-erythrocyte progenitors (MEPs) 
or granulocytic monocytic progenitors (GMPs). GMPs 
develop either into cells of the monocytic or 
granulocytic lineage. Gfi1 expression increases upon 
differentiation of CMPs towards GMPs and finally to 
granulocytes (Zeng et al., 2004). Yet, commitment of 
CMP towards MEPs and the mature erythroid and 
megakaryocytic compartment is accompanied by 
increasingly lower level of Gfi1. In this fraction, the 
paralogue Gfi1b plays a more important role (Vassen et 
al., 2007). 
B-cells 
The common lymphoid progenitors (CLPs) are thought 
to be one of the earliest B-cell precursors. During early 
B-cells differentiation, Gfi1 is expressed highest in 
CLPs and upon differentiation of CLPs into the  
different more mature B-cell progenitor fractions, Gfi1 
expression is gradually down regulated and it is hardly 
detectable in immature IgM positive B-cells (Yücel et 
al., 2004; Zeng et al., 2004). However, upon antige 
stimulation, mature B-cells induce expression of Gfi1 
(Igwe et al., 2008; Rathinam and Klein, 2007; 
Rathinam et al., 2008). 
T-cells 
T cells originate in the thymus, where they develop 
from early lymphoid progenitors (ELPs) that migrate 
from the bone marrow to the thymus where they 
become early thymic progenitors (ETPs). ETPs 
differentiate via various CD4, CD8 double negative (so
called "DN") stages to double positive (DP, CD4+, 
CD8+) cells to single positive (CD4+, CD8+) cells 
(Awong et al., 2010; Dervovic and Zúñiga-Pflücker, 
2010; Holmes and Zúñiga-Pflücker, 2009; Michie et 
al., 2007; Wang et al., 2010; Zúñiga-Pflücker, 2009; 
Zúñiga-Pflücker and van den Brink, 2007). During 
these developmental stages, Gfi1 expression is 
differentially regulated. A peak of expression is 
observed in DN3 cells at the time of beta selection 
(Yücel et al., 2004), suggesting that Gfi1 plays a role in 
this first receptor mediated selection process during pre 
T-cell development. In peripheral T-cells, Gfi1 
expression is lower than in thymocytes, but is still 
detectable and can be induced upon stimulation of the 
T cell receptor by antigen. 
Outside the hematopoietic system 
Gfi1 is also expressed in sensory epithelia such as inner 
ear hair cells, in specific cells of the retina, the 
intestinal and lung epithelia and in the central nervous 
system in Purkinje cells (see below). 
Localisation 
Gfi1 is localized in the cell nucleus and immune 
fluorescence staining demonstrates a typical dot-like 
pattern of distribution. Occasionally Gfi1 can be found 
at the nuclear membrane. These patterns vary whether 
endogenous or over-expressed Gfi1 is detected. 
Function 
The molecular function of Gfi1 is that of a DNA-
binding transcriptional repressor. A target gene 
sequence has been defined (Gilks et al., 1993; 
Zweidler-Mckay et al., 1996) and a number of target 
genes have been validated by different groups (see 
below under "Biolocigal role"). By binding to target 
gene promoters Gfi1 can recruit a number of cofactors 
that modify histone H3 N-terminal ends to the effect of 
transcriptional repression. The best characterized co-
factors are histone deacetylases (HDAC1; HDAC2; 
HDAC3), histone methyl transferases (G9a) and 
histone de-methylases (LSD1 and the LSD1-CoRest 
complex). It has been proposed that Gfi1 can initiate 
transient transcriptional silencing via histone 
deacetylation and de-methylation in particular at H3K4, 
but can also induce more permanent repression by  
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recruiting G9a, which mediates the di-methylation of 
H3K9. It is possible that other methyl transferases are 
recruited such as SUV39H1 that induce H3K9 
trimethylation and heterochromatin formation, which 
leads to permanent gene silencing (Saleque et al., 2007; 
Duan et al., 2005). 
- Biological role 
The generation of constitutive and conditional Gfi1 
deficient mouse strains has helped to elucidate the 
biological role that Gfi1 plays in the hematopoietic 
system. Similar to the approach in the passage describ  
above, we will describe the role of Gfi1 in the different 
hematopoietic compartments. 
Hematopoietic stem cells 
Gfi1-/- HSCs are characterized by their severely 
disturbed self-renewal and their inability to reconstitute 
hematopoietic lineages in a transplanted host (Hock et 
al., 2004; Möröy, 2005; Zeng et al., 2004). Two 
physiological functions of Gfi1 may explain these 
observations. Gfi1 restricts HSC proliferation by 
controlling the expression of the negative cell cycle 
regulator waf/cip1 ID: 139>. The mechanisms 
underlying this regulation are unclear, but two 
independent studies confirmed that Gfi1 deficient 
HSCs undergo more cell cycling and express reduced 
levels of p21waf/cip1 compared to HSCs from wt mice. It 
is postulated that this increased proliferation impairs 
the function of Gfi1-/-HSCs (Hock et al., 2004; Zeng et 
al., 2004). In addition, Gfi1 was found to be critial to 
protect HSCs against stress-induced apoptosis (e.g.
induced by transplantation). In support of this, 
expression of a Bcl-2 transgene that counteracts 
apoptotic signals rescued partially the defects of Gfi1 
deficient HSCs (Khandanpour et al., 2010a). 
Myeloid cells 
Gfi1 plays an important role in myeloid differentiation. 
Gfi1-/- mice have increased numbers of myeloid 
precursors (CMPs, GMPs) (Horman et al., 2009; Zeng 
et al., 2004) with an increased expression of Hoxa9, 
Pbx or Meis1. Gfi1 seems to be required to down 
regulate Hoxa9, Pbx1, Meis 1 expression to ensure a 
proper differentiation from CMPs to GMPs and finally 
to neutrophil granulocytes. Moreover, Gfi1 represses 
the expression of PU.1, CSF1R, miR-21, miR-196b, 
Egr-Nab and Id2, mostly by directly binding to their 
promoters. All of these genes are implicated in myeloid 
development (Li et al., 2010; Spooner et al., 2009; Velu 
et al., 2009). Loss of Gfi1 leads to de-repression of 
these genes favoring a development towards the 
monocytic lineage and inhibiting the development of 
granulocytes. Consequently, Gfi1-/- mice are 
neutropenic, lack granulocytes and display a strong 
expansion of atypical Mac-1+, Gr1lomonocytes 
(Karsunky et al., 2002). The requirement of Gfi1 for
the formation of neutrophil granulocytes is 
corroborated by a report that human patients with 
neutropenia carry germline mutations in the coding 
region of Gfi1 affecting the zinc finger regions (Person 
et al., 2003). 
B-cells 
Gfi1 plays a role in the early stages of B-cell 
differentiation. Evidence for this comes mainly from 
the study of Gfi1 deficient mice that show reduced 
numbers of CLPs (an early yet not fully committed B-
cell lineage progenitor) and a defective maturation of 
early B-lineage precursors, which leads to a reduce 
number of B-220+ cells in bone marrow and spleen 
(Rathinam et al., 2008). One important factor in the
early steps of B-cell development is the cytokine 
Interleukin 7 (IL-7) and its receptor IL-7R. Gfi1 
interferes with IL-7/IL-7R signaling by regulating the 
activity of Janus kinases (Jak) and subsequently the 
phosphorylation of STAT5, which is an important 
downstream signaling molecule in the IL-7R pathway. 
While the details of this regulatory function remain to 
be elucidated, Gfi1 seems to be involved in the control 
of the expression level of the Jak inhibitor SOCS3 
(Rathinam and Klein, 2007; Yasukawa et al., 2000). 
Besides the IL-7R pathway, Gfi1 also regulated the 
expression of PU.1, which is another transcription 
factor with an important role in both myeloid and 
lymphoid development. PU.1 enables precursors to 
differentiate into certain lineages and high levels favor 
myeloid over lymphoid development. Gfi1 regulates 
the function of PU.1 by two mechanisms: Gfi1 can 
form a complex with PU.1 and inhibits binding of PU.1 
to its target genes. In addition, Gfi1 also binds 
independently of PU.1 to PU.1 target genes and 
represses their transcriptional activation (Dahl et al., 
2007; Spooner et al., 2009; Wilson et al., 2010). In the 
absence of Gfi1, PU.1 is thus hyperactive and drives 
precursors into the myeloid lineage while impeding the
formation of lymphoid cells, in particular B-cells. By 
reducing PU.1 protein quantity (e.g. heterozygosity of 
PU.1) in Gfi1 deficient mice, B-cell differentiation 
defects can be overcome (Spooner et al., 2009). Based 
on these and other findings, interactive regulatory 
networks have been proposed, in which Gfi1 favors B-
cell development whereas PU.1 and Egr1 inhibit B-cell 
development and favor monocytic differentiation 
(Spooner et al., 2009). 
PU.1 and EGR1/Nab also induce the expression of 
different Id (Inhibitor of DNA binding) proteins. Gfi1 
on the other hand represses Id2 expression. Thus Gfi1-
deficiency correlates with increased Id1 and Id2 levels 
in particular thymocyte subsets (Yücel et al., 2003). Ids 
mainly function by restricting access of the 
transcription factor E2A to DNA. E2A, in conjunction 
with EBF, is required to induce B-cell specific factors 
such as Pax5 or Rag1/Rag2. Hence, high expression of 
Id proteins contributes to the Gfi1 deficiency 
phenotype (Spooner et al., 2009), as they impede up-
regulation of these important B-lineage regulators. 
Consequently knock-down or heterozygosity of Id2 in 
Gfi1 deficient mice rescues partially the disturbed 
differentiation of B-cells. To fulfill all these regulatory 
tasks, Gfi1 itself has to be induced upon initiation of B- 
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cell lineage commitment. Ikaros, another transcription 
factor important for early B-cell differentiation, acts 
upstream of Gfi1 and ensures its up-regulation after 
commitment of the progenitors to the lymphoid lineag  
(Spooner et al., 2009). 
Gfi1 is also required for the maturation and activity of 
B-cells. Gfi1 restricts an overshooting of antibody 
production after antigenic stimulation. When 
challenged with different antigens in-vivo, Gfi1 
deficient mice exhibited a higher number of 
PNA/CD19+ germinal center B-cells in the spleen and
accentuated production of antigen specific IgG2a and
IgG2b antibodies (Igwe et al., 2008). On the molecular 
level, increased level of TGF beta might explain this, as 
TGF beta promotes expression levels of different IgG
subtypes. In accordance with disturbed regulation of 
the immune response, Gfi1 deficient mice are 
characterized by an increased predisposition to develop 
autoimmune diseases (Park et al., 2005; Snapper et al., 
1993). 
T-cell development 
Gfi1 deficient mice have a reduced number of 
thymocytes compared to littermate controls (Karsunky 
et al., 2002; Yücel et al., 2003; Yücel et al., 2004). This 
is the result of a disturbed pre T-cell differentiation at 
different stages. Gfi1 is required for the proper 
transition from the DN1 to DN2 stage, to control beta 
selection in DN3 cells and to promote formation of DP
cells (Yücel et al., 2003; Yücel et al., 2004). As in the 
case of B-cell development, one explanation for these 
deficiencies is a function of Gfi1 in the regulation f 
IL-7R signaling. One hypothesis would be that 
unrestricted SOCS3 signaling in the absence of Gfi1 
would disturb IL-7 receptor signaling in thymocytes, 
but this remains to be shown. Also similar to the B-cell 
fraction, an unbalanced expression of PU.1, Egr and Id 
proteins may affect the differentiation of the ETPs to 
the different DN stages (Li et al., 2010; Spooner et al., 
2009). Other pathways that are important in pre T-cell 
development such as those initiated by Notch, Wnt or 
the pre-TCR itself remain to be analyzed in Gfi1 
deficient mice to gain more insight into the full 
spectrum of Gfi1's regulatory role in this compartment. 
Gfi1 is also implicated in the differentiation and 
activation of the mature peripheral T-cell 
subpopulations. Generally, Gfi1 is important for the 
proper function and development of CD4 T-cells 
(Pargmann et al., 2007). And more specifically, within 
the CD4 T-cell fraction, Gfi1 plays a major role in Th2 
cells. Loss of Gfi1 is associated with decreased number 
of Th2 cells and increased number of Treg-cells 
(Ichiyama et al., 2009; Shinnakasu et al., 2008; Zhu et 
al., 2006). 
- Functions of GFI1 outside the hematopoietic 
system 
Outside the hematopoietic system, Gfi1 is required for 
the integrity and function of inner ear hair cells and in 
the central nervous system for Purkinje cells. In 
addition Gfi1 plays a role in the lineage decision 
process during intestinal cell differentiation (Bjerknes 
and Cheng, 2010; Hertzano et al., 2004; Shroyer et al., 
2005; Tsuda et al., 2005; Wallis et al., 2003). Gfi1 
deficient mice show defects in all these cell lineag s, 
but the degeneration of inner ear hair cells is most 
dramatic since it leads to deafness of the animals 
(Hertzano et al., 2004; Wallis et al., 2003). 
Mutations 
Germinal 
In patients suffering from neutropenia, two types of 
mutations have been discovered to occur in the region 
of the Gfi1 gene coding for its zinc finger domains. 
This leads to amino acid replacements at two positions; 
N382S and K403R, respectively. Similar to the 
neutropenic Gfi1 deficient mice, these patients also 
display an increased number of aberrant monocytes 
(Person et al., 2003).  
In addition to these mutations, a variant form of Gfi1 
(GFI36N) was found that differs from the more 
common GFI136S form at amino acid position 36, 
where a serine is replaced by an asparagine. The 36N 
variant predisposes to the development of acute 
myeloid leukemia (AML) with an 1.6 times elevated 
risk for the carriers to develop the disease. On the 
molecular level, GFI136N features a different nuclear 
localization than the more common form of GFI 
(GFI136S). Probably as a result of this aberrant 
localization, GFI136N is no longer able to interact in-
vivo with specific binding partners or co-factors such 




Gfi1 might also be linked to lung cancer, as abundant 
Gfi1 expression was reported in a certain subtype of 
lung cancer (small cell lung cancer). In line with this 
observation, constitutive over expression of Gfi1 
enhances the malignancy of lung cancer cells 
(Kazanjian et al., 2004). 
Prostate cancer 
Note 
A role of Gfi1 in the pathogenesis of prostate cancer 
has been proposed. It was reported that 25-
Dihydroxyvitamin D (1,25D) inhibits growth of 
prostate cancer cells. The cellular synthesis of 25-
Dihydroxyvitamin D (1,25D) depends on the presence 
of 25-hydroxyvitamin D 1alpha-hydroxylase 
(CYP27B1). However the expression of this enzyme is 
repressed in prostate cancer cells. One possible 
explanation for this repression is that Gfi1, which binds 
to the promoter of this enzyme, is over expressed and 
thus represses its expression thereby contributing to 
prostate cancer development (Dwivedi et al., 2005; 
Dwivedi et al., 2007). 
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Human leukemia 
Note 
Gfi1 might be involved in the pathogenesis of chronic 
myeloid leukemia (CML). CML has a tri-phasic course 
and upon transformation from the least aggressive stage 
(chronic phase) to the most aggressive stage (blast 
crisis) an upregulation of Gfi1 expression was repoted 
(Huang et al., 2010). 
Murine leukemia 
Note 
Infection of mice with the non-acute transforming 
Moloney-type retrovirus (MoMuLV) leads to 
development of clonal T-cell lymphomas (Mikkers and 
Berns, 2003). Common proviral insertions that are 
selected for during tumorigenesis typically include 
genomic areas close to neighbouring oncogenes. The 
Gfi1 gene is one of the most frequent common 
insertion sites in MoMuLV induced tumors, 
comparable to sites close to the c-Myc and Pim-1 
oncogenes (Scheijen et al., 1997; Schmidt et al., 1998; 
Zörnig et al., 1996). This suggested a causal role of 
Gfi1 in T-cell tumorigenesis. Constitutive over 
expression of Gfi1 accelerated the onset of T-cell 
leukemia in conjunction with the expression of other 
oncogenes such as Pim1 or L-Myc (Schmidt et al., 
1998; Zörnig et al., 1996). These early experiments 




Loss of Gfi1 induces a number of autoimmune diseases 
in mice, which can be explained by the loss of function 
of Gfi1 deficient B- and T-cells. So far, a role for Gfi1 
in human autoimmune diseases has yet to be found 
(Rathinam et al., 2008). 
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